Previous study showed that HNRNPA2B1, an m6A methylation regulator, was not only highly expressed in patients with high Gleason score but also significantly associated with unfavorable BCR-free survival in PCa patients (60). The gene discussed is HNRNPA2B1; the disease is posterior cortical atrophy.